Citations

Mayo Clinic

Clear

69 citation(s) found for "Ra, Seong".

Metabolomic Analyses Reveal Extensive Progenitor Cell Deficiencies in a Mouse Model of Duchenne Muscular Dystrophy
Joseph, Josiane , Cho, Dong Seong , Doles, Jason D. , Doles, Jason D

Metabolites | October 4, 2018 | Volume: 8 | Issue: 4 | Pages: 61

10.3390/metabo8040061 | PMID 30282911 Get It

Duchenne muscular dystrophy (DMD) is a musculoskeletal disorder that causes severe morbidity and reduced lifespan. Individuals with DMD have an X-linked mutation that impairs their ability to produce functional dystrophin protein in muscle. No cure exists for this disease and the few therapies that are available do not dramatically delay disease progression. Thus, there is a need to better understand the mechanisms underlying DMD which may ultimately lead to improved treatment options. The muscular dystrophy (MDX) mouse model is frequently used to explore DMD disease traits. Though some studies of metabolism in dystrophic mice exist, few have characterized metabolic profiles of supporting cells in the diseased environment. Using nontargeted metabolomics we characterized metabolic alterations in muscle satellite cells (SCs) and serum of MDX mice. Additionally, live-cell imaging revealed MDX-derived adipose progenitor cell (APC) defects. Finally, metabolomic studies revealed a striking elevation of acylcarnitines in MDX APCs, which we show can inhibit APC proliferation. Together, these studies highlight widespread metabolic alterations in multiple progenitor cell types and serum from MDX mice and implicate dystrophy-associated metabolite imbalances in APCs as a potential contributor to adipose tissue disequilibrium in DMD.
Difficulty scoring system in laparoscopic distal pancreatectomy
Ohtsuka, Takao , Ban, Daisuke , Tanabe, Minoru , Gotoh, Yoshitaka , Velasquez, Vittoria Vanessa, Nakata, Kohei , Sahara, Yatsuka, Takaori, Kyoichi , Misawa, Takeyuki , Yamaue, Hiroki , Morikawa, Takanori , Kuroki, Tamotsu, Mou, Yiping , Lee, Woo Jung , Shrikhande, Shailesh V. , Tang, Chung Ngai, Conrad, Claudius , Palanivelu, Chinnusamy , Asbun, Horacio J. , Kooby, David A. , Wakabayashi, Go , Takada, Tadahiro , Yamamoto, Masakazu , Nakata, Kohei , Nakamura, Yoshiharu , Nagakawa, Yuichi , Honda, Goro , Kawai, Manabu , Han, Ho-Seong , Nakamura, Masafumi

Journal of Hepato-Biliary-Pancreatic Sciences | August 17, 2018 | Volume: 25 | Issue: 11 | Pages: 489-497

10.1002/jhbp.578 | PMID 30118575 Get It

AbstractBackgroundSeveral factors affect the level of difficulty of laparoscopic distal pancreatectomy (LDP). The purpose of this study was to develop a difficulty scoring (DS) system to quantify the degree of difficulty in LDP.MethodsWe collected clinical data for 80 patients who underwent LDP. A 10‐level difficulty index was developed and subcategorized into a three‐level difficulty index; 1–3 as low, 4–6 as intermediate, and 7–10 as high index. The automatic linear modeling (LINEAR) statistical tool was used to identify factors that significantly increase level of difficulty in LDP.ResultsThe operator's 10‐level DS concordance between the 10‐level DS by the reviewers, LINEAR index DS, and clinical index DS systems were analyzed, and the weighted Cohen's kappa statistic were at 0.869, 0.729, and 0.648, respectively, showing good to excellent inter‐rater agreement. We identified five factors significantly affecting level of difficulty in LDP; type of operation, resection line, proximity of tumor to major vessel, tumor extension to peripancreatic tissue, and left‐sided portal hypertension/splenomegaly.ConclusionsThis novel DS for LDP adequately quantified the degree of difficulty, and can be useful for selecting patients for LDP, in conjunction with fitness for surgery and prognosis.
Uncoupled Endothelial Nitric Oxide Synthase Enhances p-Tau in Chronic Traumatic Encephalopathy Mouse Model
Shin, Nara , Kim, Hyeong-Geug , Kwon, Hyeok Hee , Yi, Min‐Hee , Zhang, Enji, Kim, Jwa-Jin, Hong, Jinpyo , Lee, Sun Yeul , Lee, Won Hyung , Triantafillu, Ursula L., Kim, Cuk‐Seong , Kim, Yonghyun , Kim, Dong Woon , Kim, Yonghyun , Kim, Dong Woon , Shin, Hyo Jung , Kim, Sena , Baek, Hyunjung

Antioxidants & Redox Signaling | August 2, 2018 | Volume: 30 | Issue: 13 | Pages: 1601-1620

10.1089/ars.2017.7280 | PMID 30070145 Get It

Aims: Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease thought to be caused by repetitive traumatic brain injury (TBI) and subconcussive injuries. While hyperphosphorylation of tau (p-Tau), which is attributed to astrocytic tangles (ATs) and neurofibrillary tangles, is known to be involved in CTE, there are limited neuropathological or molecular data. By utilizing repetitive mild TBI (rmTBI) mouse models, our aim was to examine the pathological changes of CTE-associated structures, specifically the ATs. Results: Our rmTBI mouse models showed symptoms of depressive behavior and memory deficit, alongside an increased p-Tau expression in their neurons and astrocytes in both the hippocampus and cortex. rmTBI induced oxidative stress in endothelial cells and nitric oxide (NO) generation in astrocytes, which were mediated by hypoxia and increased hypoxia-inducible factor 1-α (HIF1α). There was also correlated decreased regional cerebral tissue perfusion units, mild activation of astrocytes and NFκB phosphorylation, increased expression of inducible nitric oxide synthase (iNOS), increased endothelial nitric oxide synthase (eNOS) uncoupling with decreased tetrahydrobiopterin, and increased expression of nitrotyrosine, NADPH oxidase 2 (Nox2)/nuclear factor (erythroid-derived 2) factor 2 (Nrf2) signaling proteins. Combined, these effects induced peroxynitrite formation and hyperphosphorylation of tau in the hippocampus and cortex toward the formation of ATs. Innovation: Our model features molecular pathogenesis events of CTE with clinically relevant latency periods. In particular, this is the first demonstration of an increased astrocytic iNOS expression in an in vivo model. Conclusion: We propose a novel mechanism of uncoupled eNOS and NO contribution to Tau phosphorylation and AT formation in rmTBI brain, toward an increased molecular understanding of the pathophysiology of human CTE.
Laparoscopic Donor Hepatectomy for Adult Living Donor Liver Transplantation Recipients
Kwon, Choon Hyuck David , Kim, Gaab Soo , Choi, Gyu‐Seong , Kim, Jong Man , Cho, Chan Woo , Rhu, Jinsoo , Sinn, Dong Hyun , Joh, Jae-Won

Liver Transplantation | July 19, 2018 | Volume: 24 | Issue: 11 | Pages: 1545-1553

10.1002/lt.25307 | PMID 30021060 Get It

Even after 2 decades of experience in laparoscopic hepatectomy, data on purely laparoscopic approach for donor hepatectomy in adult living donor liver transplantation (LDLT) are limited. We report our initial experience of a purely laparoscopic approach for donor hepatectomy for adult recipients to explore its potential application in the management of donors. We did a retrospective data analysis of 54 consecutive patients operated on between May 2013 and February 2015. There were 41 right, 10 extended right, and 3 left hepatectomies. The median operative time was 436 minutes (range 294‐684 minutes), and warm ischemia time was 6 minutes (2‐12 minutes). Estimated blood loss was 300 mL (10‐850 mL), and none of the patients required intraoperative transfusion. Four cases were converted to open laparotomy. The major complication rate was 16.7%, and biliary complication was the most frequent cause. Patients with normal anatomy had a major complication rate of 9.3% as compared with 45.5% in patients with anatomic variations. All patients recovered, and there was no mortality. In conclusion, a purely laparoscopic donor hepatectomy for adult LDLT recipients seems to be a feasible option; with careful patient selection and when performed by experienced surgeons, it may afford results comparable to the open method.
Minimally invasive preservation versus splenectomy during distal pancreatectomy: a systematic review and meta‐analysis
Nakata, Kohei , Shikata, Satoru , Ohtsuka, Takao , Miyasaka, Yoshihiro , Mori, Yasuhisa , Velasquez, Vittoria Vanessa, Gotoh, Yoshitaka , Ban, Daisuke , Tanabe, Minoru , Sahara, Yatsuka, Takaori, Kyoichi , Misawa, Takeyuki , Yamaue, Hiroki , Morikawa, Takanori , Kuroki, Tamotsu, Mou, Yiping , Lee, Woo Jung , Shrikhande, Shailesh V. , Tang, Chung Ngai, Conrad, Claudius , Chinnusamy, Palanivelu, Asbun, Horacio J. , Kooby, David A. , Wakabayashi, Go , Takada, Tadahiro , Yamamoto, Masakazu , Nakata, Kohei , Ukai, Tomohiko , Nakamura, Yoshiharu , Nagakawa, Yuichi , Honda, Goro , Kawai, Manabu , Han, Ho-Seong , Nakamura, Masafumi

Journal of Hepato-Biliary-Pancreatic Sciences | June 26, 2018 | Volume: 25 | Issue: 11 | Pages: 476-488

10.1002/jhbp.569 | PMID 29943909 Get It

AbstractBackgroundMinimally invasive distal pancreatectomy (MIDP) has gained in popularity recently. However, there is no consensus on whether to preserve the spleen or not. In this study, we compared MIDP outcomes between spleen‐preserving distal pancreatectomy (SPDP) and distal pancreatectomy with splenectomy (DPS); as well as outcomes between splenic vessel preservation (SVP) and Warshaw's technique (WT).MethodsA systematic search of PubMed (MEDLINE) and Cochrane Library was conducted and the reference lists of review articles were hand‐searched.ResultsFifteen relevant studies with 769 patients were selected for meta‐analyses of DPS and SPDP, while another 15 studies with 841 patients were used for the analysis between SVP and WT. Compared with the DPS group, SPDP patients had significantly lower incidences of infectious complications (P = 0.006) and pancreatic fistula (P = 0.002), shorter operative time (P < 0.001), and less blood loss (P = 0.01). Compared with WT, SVP patients had significantly lower incidences of splenic infarction (P < 0.001) and secondary splenectomy (P = 0.003). Subanalysis for laparoscopic surgery alone had similar results.ConclusionsBased on this study, SPDP has significantly superior outcomes compared to DPS. When a spleen is preserved, SVP has better outcomes over WT for reducing splenic complications.
Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos)
Wakabayashi, Go , Iwashita, Yukio , Hibi, Taizo , Takada, Tadahiro , Strasberg, Steven M. , Asbun, Horacio J. , Endo, Itaru , Umezawa, Akiko , Asai, Koji , Mori, Yasuhisa , Okamoto, Kohji , Pitt, Henry A. , Hwang, Tsann‐Long , Choi, In‐Seok , Huang, Wayne Shih‐Wei, Giménez, Mariano , Garden, O. James , Gouma, Dirk J., Belli, Giulio, Dervenis, Christos, Jagannath, P., Chan, Angus C. W., Lau, Wan Yee , Liu, Keng‐Hao, Su, Cheng‐Hsi, Misawa, Takeyuki , Tagaya, Nobumi, Fujioka, Shuichi , Higuchi, Ryota , Shikata, Satoru , Noguchi, Yoshinori , Yokoe, Masamichi, Cherqui, Daniel , Sugioka, Atsushi , Santibáñes, Eduardo de , Supe, Avinash , Tokumura, Hiromi, Kimura, Taizo, Yoshida, Masahiro , Mayumi, Toshihiko , Kitano, Seigo, Inomata, Masafumi , Sumiyama, Yoshinobu, Inui, Kazuo, Yamamoto, Masakazu , Suzuki, Kenji S. , Han, Ho-Seong , Yoon, Yoo-Seok , Yoon, Dong Sup , Nakamura, Masafumi , Horiguchi, Akihiko , Ukai, Tomohiko , Honda, Goro , Hirata, Koichi

Journal of Hepato-Biliary-Pancreatic Sciences | November 2, 2017 | Volume: 25 | Issue: 1 | Pages: 73-86

10.1002/jhbp.517 | PMID 29095575 Get It

Abstract In some cases, laparoscopic cholecystectomy (LC) may be difficult to perform in patients with acute cholecystitis (AC) with severe inflammation and fibrosis. The Tokyo Guidelines 2018 (TG18) expand the indications for LC under difficult conditions for each level of severity of AC. As a result of expanding the indications for LC to treat AC, it is absolutely necessary to avoid any increase in bile duct injury (BDI), particularly vasculo‐biliary injury (VBI), which is known to occur at a certain rate in LC. Since the Tokyo Guidelines 2013 (TG13), an attempt has been made to assess intraoperative findings as objective indicators of surgical difficulty; based on expert consensus on these difficulty indicators, bail‐out procedures (including conversion to open cholecystectomy) have been indicated for cases in which LC for AC is difficult to perform. A bail‐out procedure should be chosen if, when the Calot's triangle is appropriately retracted and used as a landmark, a critical view of safety (CVS) cannot be achieved because of the presence of nondissectable scarring or severe fibrosis. We propose standardized safe steps for LC to treat AC. To achieve a CVS, it is vital to dissect at a location above (on the ventral side of) the imaginary line connecting the base of the left medial section (Segment 4) and the roof of Rouvière's sulcus and to fulfill the three criteria of CVS before dividing any structures. Achieving a CVS prevents the misidentification of the cystic duct and the common bile duct, which are most commonly confused. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47 . Related clinical questions and references are also included.
Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis
Mayumi, Toshihiko , Okamoto, Kohji , Takada, Tadahiro , Strasberg, Steven M. , Solomkin, Joseph S. , Schlossberg, David, Pitt, Henry A. , Yoshida, Masahiro , Gomi, Harumi , Miura, Fumihiko, Garden, O. James , Kiriyama, Seiki , Yokoe, Masamichi, Endo, Itaru , Asbun, Horacio J. , Iwashita, Yukio , Hibi, Taizo , Umezawa, Akiko , Itoi, Takao , Hata, Jiro , Hwang, Tsann‐Long , Dervenis, Christos, Asai, Koji , Mori, Yasuhisa , Huang, Wayne Shih‐Wei, Belli, Giulio, Jagannath, P., Cherqui, Daniel , Kozaka, Kazuto , Baron, Todd H. , Santibáñes, Eduardo de , Higuchi, Ryota , Wada, Keita, Gouma, Dirk J., Deziel, Daniel J., Liau, Kui‐Hin, Wakabayashi, Go , Padbury, Robert , Jonas, Eduard , Supe, Avinash , Singh, Harjit , Gabata, Toshifumi , Chan, Angus C. W., Lau, Wan Yee , Fan, Sheung Tat , Chen, Miin‐Fu , Ker, Chen‐Guo , Choi, In‐Seok , Kim, Myung‐Hwan , Kitano, Seigo, Inomata, Masafumi , Inui, Kazuo, Sumiyama, Yoshinobu, Yamamoto, Masakazu , Suzuki, Kenji S. , Han, Ho-Seong , Mukai, Shuntaro , Yoon, Yoo-Seok , Yoon, Dong Sup , Hirata, Koichi , Jonas, Eduard

Journal of Hepato-Biliary-Pancreatic Sciences | November 1, 2017 | Volume: 25 | Issue: 1 | Pages: 96-100

10.1002/jhbp.519 | PMID 29090868 Get It

Abstract Management bundles that define items or procedures strongly recommended in clinical practice have been used in many guidelines in recent years. Application of these bundles facilitates the adaptation of guidelines and helps improve the prognosis of target diseases. In Tokyo Guidelines 2013 ( TG 13), we proposed management bundles for acute cholangitis and cholecystitis. Here, in Tokyo Guidelines 2018 ( TG 18), we redefine the management bundles for acute cholangitis and cholecystitis. Critical parts of the bundles in TG 18 include the diagnostic process, severity assessment, transfer of patients if necessary, and therapeutic approach at each time point. Observance of these items and procedures should improve the prognosis of acute cholangitis and cholecystitis. Studies are now needed to evaluate the dissemination of these TG 18 bundles and their effectiveness. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47 . Related clinical questions and references are also included.
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
Meehan, Terrence F. , Goldstein, Theodore C. , Murakami, Mark A. , Brabetz, Sebastian , Gu, Zhiping , Wiser, Jeffrey A., Dunn, Patrick , Begley, Dale A. , Krupke, Debra M. , Bertotti, Andrea , Bruna, Alejandra , Brush, Matthew , Byrne, Annette T. , Caldas, Carlos , Christie, Amanda L., Clark, Dominic A. , Dowst, Heidi , Dry, Jonathan R. , Doroshow, James H. , Duchamp, Olivier, Ferretti, Stéphane , Frese, Kristopher K. , Goodwin, Neal , Greenawalt, Danielle M., Haendel, Melissa , Hermans, Els , Houghton, Peter J. , Jonkers, Jos , Kemper, Kristel , Khor, Tin Oo, Lloyd, K. C. Kent , Mason, Jeremy , Médico, Enzo , Olson, James M. , Peeper, Daniel S. , Seong, Je Kyung , Trusolino, Livio , Vinolo, Emilie, Wechsler‐Reya, Robert J. , Weinstock, David M. , Welm, Alana L. , Weroha, S. John , Pfister, Stefan M. , Kool, Marcel , Parkinson, Helen , Butte, Atul J. , Bult, Carol J. , Haendel, Melissa , Caldas, Carlos , Pfister, Stefan M , Conte, Nathalie , Inghirami, Giorgio , Evrard, Yvonne A. , Lewis, Michael T. , Neuhauser, Steven B. , Rueda, Oscar M. , Amant, Frédéric

Cancer Research | November 1, 2017 | Volume: 77 | Issue: 21 | Pages: e62-e66

10.1158/0008-5472.can-17-0582 | PMID 29092942 Get It

Abstract Patient-derived tumor xenograft (PDX) mouse models have emerged as an important oncology research platform to study tumor evolution, mechanisms of drug response and resistance, and tailoring chemotherapeutic approaches for individual patients. The lack of robust standards for reporting on PDX models has hampered the ability of researchers to find relevant PDX models and associated data. Here we present the PDX models minimal information standard (PDX-MI) for reporting on the generation, quality assurance, and use of PDX models. PDX-MI defines the minimal information for describing the clinical attributes of a patient's tumor, the processes of implantation and passaging of tumors in a host mouse strain, quality assurance methods, and the use of PDX models in cancer research. Adherence to PDX-MI standards will facilitate accurate search results for oncology models and their associated data across distributed repository databases and promote reproducibility in research studies using these models. Cancer Res; 77(21); e62–66. ©2017 AACR.
Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis
Okamoto, Kohji , Takada, Tadahiro , Strasberg, Steven M. , Asbun, Horacio J. , Endo, Itaru , Iwashita, Yukio , Hibi, Taizo , Pitt, Henry A. , Umezawa, Akiko , Asai, Koji , Hwang, Tsann‐Long , Mori, Yasuhisa , Huang, Wayne Shih‐Wei, Belli, Giulio, Dervenis, Christos, Yokoe, Masamichi, Kiriyama, Seiki , Itoi, Takao , Jagannath, P., Garden, O. James , Miura, Fumihiko, Wakabayashi, Go , Cherqui, Daniel , Santibáñes, Eduardo de , Shikata, Satoru , Noguchi, Yoshinori , Higuchi, Ryota , Wada, Keita, Supe, Avinash , Yoshida, Masahiro , Mayumi, Toshihiko , Gouma, Dirk J., Deziel, Daniel J., Liau, Kui‐Hin, Chen, Miin‐Fu , Shibao, Kazunori , Liu, Keng‐Hao, Su, Cheng‐Hsi, Chan, Angus C. W., Choi, In‐Seok , Jonas, Eduard , Fan, Sheung Tat , Ker, Chen‐Guo , Giménez, Mariano , Kitano, Seigo, Inomata, Masafumi , Inui, Kazuo, Sumiyama, Yoshinobu, Yamamoto, Masakazu , Suzuki, Kenji S. , Han, Ho-Seong , Yoon, Yoo-Seok , Nakamura, Masafumi , Horiguchi, Akihiko , Ukai, Tomohiko , Honda, Goro , Yoon, Dong Sup , Chen, Xiaoping , Hirata, Koichi , Jonas, Eduard

Journal of Hepato-Biliary-Pancreatic Sciences | October 16, 2017 | Volume: 25 | Issue: 1 | Pages: 55-72

10.1002/jhbp.516 | PMID 29045062 Get It

Abstract We propose a new flowchart for the treatment of acute cholecystitis ( AC ) in the Tokyo Guidelines 2018 (TG18). Grade III AC was not indicated for straightforward laparoscopic cholecystectomy (Lap‐C). Following analysis of subsequent clinical investigations and drawing on Big Data in particular, TG 18 proposes that some Grade III AC can be treated by Lap‐C when performed at advanced centers with specialized surgeons experienced in this procedure and for patients that satisfy certain strict criteria. For Grade I, TG 18 recommends early Lap‐C if the patients meet the criteria of Charlson comorbidity index ( CCI ) ≤5 and American Society of Anesthesiologists physical status classification ( ASA ‐ PS ) ≤2. For Grade II AC , if patients meet the criteria of CCI ≤5 and ASA ‐ PS ≤2, TG 18 recommends early Lap‐C performed by experienced surgeons; and if not, after medical treatment and/or gallbladder drainage, Lap‐C would be indicated. TG 18 proposes that Lap‐C is indicated in Grade III patients with strict criteria. These are that the patients have favorable organ system failure, and negative predictive factors, who meet the criteria of CCI ≤3 and ASA ‐ PS ≤2 and who are being treated at an advanced center (where experienced surgeons practice). If the patient is not considered suitable for early surgery, TG 18 recommends early/urgent biliary drainage followed by delayed Lap‐C once the patient's overall condition has improved. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47 . Related clinical questions and references are also included.
Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)
Yokoe, Masamichi, Hata, Jiro , Takada, Tadahiro , Strasberg, Steven M. , Asbun, Horacio J. , Wakabayashi, Go , Kozaka, Kazuto , Endo, Itaru , Deziel, Daniel J., Miura, Fumihiko, Okamoto, Kohji , Hwang, Tsann‐Long , Huang, Wayne Shih‐Wei, Ker, Chen‐Guo , Chen, Miin‐Fu , Choi, In‐Seok , Noguchi, Yoshinori , Shikata, Satoru , Higuchi, Ryota , Gabata, Toshifumi , Mori, Yasuhisa , Iwashita, Yukio , Hibi, Taizo , Jagannath, P., Jonas, Eduard , Liau, Kui‐Hin, Dervenis, Christos, Gouma, Dirk J., Cherqui, Daniel , Belli, Giulio, Garden, O. James , Giménez, Mariano , Santibáñes, Eduardo de , Umezawa, Akiko , Supe, Avinash , Pitt, Henry A. , Singh, Harjit , Chan, Angus C. W., Lau, Wan Yee , Sugioka, Atsushi , Asai, Koji , Gomi, Harumi , Itoi, Takao , Kiriyama, Seiki , Yoshida, Masahiro , Mayumi, Toshihiko , Matsumura, Naoki , Tokumura, Hiromi, Kitano, Seigo, Inui, Kazuo, Sumiyama, Yoshinobu, Yamamoto, Masakazu , Han, Ho-Seong , Yoon, Yoo-Seok , Yoon, Dong Sup , Ukai, Tomohiko , Suzuki, Kenji S. , Teoh, Anthony Yuen Bun , Honda, Goro , Hirata, Koichi , Jonas, Eduard

Journal of Hepato-Biliary-Pancreatic Sciences | October 15, 2017 | Volume: 25 | Issue: 1 | Pages: 41-54

10.1002/jhbp.515 | PMID 29032636 Get It

Abstract The Tokyo Guidelines 2013 (TG13) for acute cholangitis and cholecystitis were globally disseminated and various clinical studies about the management of acute cholecystitis were reported by many researchers and clinicians from all over the world. The 1 st edition of the Tokyo Guidelines 2007 ( TG 07) was revised in 2013. According to that revision, the TG 13 diagnostic criteria of acute cholecystitis provided better specificity and higher diagnostic accuracy. Thorough our literature search about diagnostic criteria for acute cholecystitis, new and strong evidence that had been released from 2013 to 2017 was not found with serious and important issues about using TG 13 diagnostic criteria of acute cholecystitis. On the other hand, the TG 13 severity grading for acute cholecystitis has been validated in numerous studies. As a result of these reviews, the TG 13 severity grading for acute cholecystitis was significantly associated with parameters including 30‐day overall mortality, length of hospital stay, conversion rates to open surgery, and medical costs. In terms of severity assessment, breakthrough and intensive literature for revising severity grading was not reported. Consequently, TG 13 diagnostic criteria and severity grading were judged from numerous validation studies as useful indicators in clinical practice and adopted as TG 18/ TG 13 diagnostic criteria and severity grading of acute cholecystitis without any modification. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47 . Related clinical questions and references are also included.